
MIT's AI-Designed Antibiotic 'Abaucin' Eradicates Drug-Resistant Superbugs in Global Trials
MIT researchers have announced the Phase 3 success of Abaucin, the first entirely AI-designed antibiotic, which demonstrated superior efficacy and saf...
Read Full Story →




